$VTRS ($VTRS) is expected to release its quarterly earnings data on Thursday, May 8th before market open, per Finnhub. Analysts are expecting revenue of ...

Viatris Inc. (VTRS) is a global healthcare company valued at a market cap of $12 billion. It focuses on providing affordable medicines across a wide range of therapeutic areas, including ...

Viatris (NASDAQ:VTRS) shares recorded modest gains in the premarket on Thursday after the Xanax maker announced positive outcomes to several Phase 3 trials alongside better-than-expected financials ...

We recently published a list of the 10 Best Cheap Stocks to Buy Under $10. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other cheap stocks to buy ...

Viatris (VTRS) reported $3.25 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 11.2%. EPS of $0.50 for the same period compares to $0.67 a year ago. The ...

On November 6, 2025, Viatris reported strong financial results for the third quarter of 2025, with total revenues aligning with expectations. The company made significant progress in its late-stage ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) ...

On this news, the price of Viatris stock declined roughly 15% during the trading day, from a closing price of $11.24 per share on February 26, 2025, to $9.53 per share on February 27, 2025.